Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Drug Discovery and Translational Medicine

  • You have access
    Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222
    Ashvani K. Singh, Yihong Fan, Corina Balut, Sara Alani, Arlene M. Manelli, Andrew M. Swensen, Ying Jia, Torben R. Neelands, Timothy A. Vortherms, Bo Liu, Xenia B. Searle, Xueqing Wang, Wenqing Gao, Tzyh-Chang Hwang, Hong Y. Ren, Douglas Cyr, Philip R. Kym, Katja Conrath and Chris Tse
    Journal of Pharmacology and Experimental Therapeutics January 2020, 372 (1) 107-118; DOI: https://doi.org/10.1124/jpet.119.261800
  • You have access
    The Positive Allosteric Modulator of α2/3-Containing GABAA Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury
    Jeffrey M. Witkin, Guanguan Li, Lalit K. Golani, Wenhui Xiong, Jodi L. Smith, Xingjie Ping, Farjana Rashid, Rajwana Jahan, Rok Cerne, James M. Cook and Xiaoming Jin
    Journal of Pharmacology and Experimental Therapeutics January 2020, 372 (1) 83-94; DOI: https://doi.org/10.1124/jpet.119.260968
  • You have access
    A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer
    Jiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, Dong-Hoon Lee, Karl J. Okolotowicz and John R. Cashman
    Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 703-712; DOI: https://doi.org/10.1124/jpet.119.261040
  • You have access
    A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
    Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
    Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869
  • Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
    You have access
    Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
    John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
    Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188
  • Open Access
    The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
    Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
    Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059
  • You have access
    Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
    Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
    Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135
  • You have access
    Pharmacological Profile of JNJ-64179375: A Novel, Long-Acting Exosite-1 Thrombin Inhibitor
    Zheng Huang Devine, Fuyong Du, Qiu Li, Matthew Bunce, Eilyn R. Lacy and Madhu Chintala
    Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 375-384; DOI: https://doi.org/10.1124/jpet.119.261032
  • You have access
    In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution
    Staci L. Haney, Yashpal S. Chhonker, Michelle L. Varney, Geoffrey Talmon, Lynette M. Smith, Daryl J. Murry and Sarah A. Holstein
    Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 327-338; DOI: https://doi.org/10.1124/jpet.119.258624
  • You have access
    Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
    Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
    Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028

Pages

  • Previous
  • Next
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 51
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics